The Assessment of Subclinical Ifosfamide-Induced Renal Tubular Toxicity Using Urinary Excretion of Retinol-Binding Protein
- 1 January 1993
- journal article
- research article
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 10 (2) , 119-128
- https://doi.org/10.3109/08880019309016545
Abstract
The excretion of retinol-binding protein in early morning urine samples, expressed as a ratio to urinary creatinine (RBPCR), was used as a measure of proximal renal tubular toxicity in children during or after treatment with ifosfamide-containing chemotherapy. The results showed a progressive increase in renal tubular leak after exposure to ifosfamide that persisted after treatment. The toxic effect appeared to be greatest in younger children and at least partly dose-dependent, although partially reversible after each course of chemotherapy. However, few patients had related symptoms and none experienced major metabolic difficulty.Keywords
This publication has 5 references indexed in Scilit:
- Hyperaminoaciduria identifies patients at risk of developing renal tubular toxicity associated with ifosfamide and platinate containing regimensMedical and Pediatric Oncology, 1992
- Ifosfamide, Fanconi's syndrome, and rickets.Journal of Clinical Oncology, 1991
- Progressive renal toxicity due to ifosfamide.Archives of Disease in Childhood, 1991
- Nephrotoxicity after ifosfamide.Archives of Disease in Childhood, 1990
- Hypophosphataemic rickets after ifosfamide treatment in children.BMJ, 1989